What is your approach for endocrine therapy in young women (<35 years old) with HR+/HER2+ breast CA with residual disease after TCHP who will start adjuvant T-DM1?   


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Northwestern Medicine Cancer Center at KishHealth
Would you start anti estrogen therapy concurrently...
Medical Oncologist at Cedars-Sinai Medical Center
I agree that I would give OFS plus an AI in this h...
Medical Oncologist at Boston University School of Medicine
Neratinib (for 12 months) is also approved after c...
Medical Oncologist at Clinical Instructor
The question of concurrent anti-endocrine therapy ...
Medical Oncologist at NYU Winthrop Hospital
The SOFT/TEXT trial was done in ER positive tumors...
Medical Oncologist at University of Texas MD Anderson Cancer Center
Actually, 14% of patients had HER2 positive diseas...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice